Protein-coding gene expression profiling, such as estrogen receptor (ER)+, Triple negative, and human epidermal growth factor receptor (HER)2+, helps in addressing breast cancer clinical treatment (2). The gene discussed is ERBB2; the disease is breast carcinoma.